Turning to "Omics" in Understanding Fontan-Associated Liver Disease

J Am Coll Cardiol. 2024 Feb 20;83(7):739-740. doi: 10.1016/j.jacc.2023.12.025.

Authors

Yuli Y Kim¹, Maarouf A Hoteit²

Affiliations

¹ Division of Cardiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. Electronic address: Yuli.Kim@pennmedicine.upenn.edu.
² Division of Gastroenterology and Hepatology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

PMID: 38355243
DOI: 10.1016/j.jacc.2023.12.025

No abstract available

Keywords: Fontan outcomes; Fontan-associated liver disease; liver fibrosis; single ventricle; transcriptomics.

Publication types

Editorial

MeSH terms

Fontan Procedure* / adverse effects
Heart Defects, Congenital* / complications
Humans
Liver
Liver Diseases* / complications